Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss
An argument for clarifying the nomenclature
An expert talks through the benefits, limits and unresolved questions of an evolving technology
Recommendations on identifying and managing neurodevelopmental and related challenges
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies
Aim is for use with clinician oversight to make screening safer and more efficient
Planning continues with critical, patient-focused input from nursing teams
Rapid innovation is shaping the deep brain stimulation landscape
Study shows short-term behavioral training can yield objective and subjective gains
How we’re efficiently educating patients and care partners about treatment goals, logistics, risks and benefits
Advertisement
Advertisement